1. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations;Bartelink;Clin. Pharmacokinet.,2006
2. Female puberty: Clinical implications for the use of prolactine-modulating psychotropics;Becker;Child Adolesc. Psychiatr. Clin. N. Am.,2006
3. Birmaher, B. and Brent, D. (2007);
4. AACAP Work Group on Quality Issues, Bernet, W., Bukstein, O., Walter, H., Benson, R.S., Chrisman, A., Farchione, T., Greenhill, L., Hamilton, J., Keable, H., Kinlan, J., Schoettle, U., Stock, S., Ptakowski, K.K., Medicus, J. Practice Parameter for the Assessment and Treatment of Children and Adolescents With Depressive Disorders. J Am Acad Child Adolesc Psychiatry, 46, 1503–1526.
5. Child and adolescent psychiatry in the Netherlands: patterns of practice 7 years later;Boer;Eur. Child Adolesc. Psychiatry,2005